Comments
Loading...

AdvisorShares Psychedelics ETF

PSILARCA
Logo brought to you by Benzinga Data
$10.62
0.121.15%
At close: -
$11.26
0.645.99%
After Hours: Dec 13, 6:11 PM EDT
Sector
Healthcare
Region
US
AUM
5.19M
Fund Score

AdvisorShares Psychedelics ETF (ARCA:PSIL) Quotes, Forecast and News Summary

AdvisorShares Psychedelics ETF (ARCA: PSIL) stock price, news, charts, stock research, profile.

Open$10.50
High$10.63
52 Wk High$17.00
AUM5.19M
Dividend$0.12
Ex-Div DateSep 25, 2023
Volume3.66K
Market Cap$1.59B
Mgmt Fee0.6%
P/E Ratio13.03
Prev. Close$10.50
Low$10.50
52 Wk Low$0.80
Shares Out5.62M
Yield13.18%
Div. FreqQuarterly
Avg. Volume Daily54.11K
Beta0.90
Avg. Expense RatioNA%
P/B Ratio2.16

FAQ

Q

How do I buy AdvisorShares Psychedelics ETF (PSIL) stock?

A

You can purchase shares of AdvisorShares Psychedelics ETF (ARCA:PSIL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AdvisorShares Psychedelics ETF (PSIL) competitors?

A

There are no as such competitors for AdvisorShares Psychedelics ETF.

Q

What is the forecast, or price target, for AdvisorShares Psychedelics ETF (PSIL) stock?

A

There is no analysis for AdvisorShares Psychedelics ETF to provide a consensus price target.

Q

What is the current price for AdvisorShares Psychedelics ETF (PSIL)?

A

The stock price for AdvisorShares Psychedelics ETF (ARCA: PSIL) is $11.26 last updated December 13, 2024 at 6:11 PM EST.

Q

Does AdvisorShares Psychedelics ETF (PSIL) pay a dividend?

A

There are no upcoming dividends for AdvisorShares Psychedelics ETF.

Q

When is AdvisorShares Psychedelics ETF (ARCA:PSIL) reporting earnings?

A

AdvisorShares Psychedelics ETF does not have any upcoming earnings scheduled.

Q

Is AdvisorShares Psychedelics ETF (PSIL) going to split?

A

There is no upcoming split for AdvisorShares Psychedelics ETF.

Open$10.50
High$10.63
52 Wk High$17.00
AUM5.19M
Dividend$0.12
Ex-Div DateSep 25, 2023
Volume3.66K
Market Cap$1.59B
Mgmt Fee0.6%
P/E Ratio13.03
Prev. Close$10.50
Low$10.50
52 Wk Low$0.80
Shares Out5.62M
Yield13.18%
Div. FreqQuarterly
Avg. Volume Daily54.11K
Beta0.90
Avg. Expense RatioNA%
P/B Ratio2.16
ETF Details
SectorHealthcare
CategoryMid Performer-Low Growth
Investment StyleLarge Cap Value
Fund InceptionSep 15, 2021
Managers
Dan S. Ahrens
DefinitionMajority of stocks in this Equity Fund have average Financial performance and low growth potential
Investment Policy
The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and (ii) derivatives that have economic characteristics similar to such securities. The Fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The Fund invests in exchange-listed equity securities, including common and preferred stock of U.S. and foreign mid, small and micro-capitalization companies, and in total return swaps intended to provide exposure to such companies.
Top ETF Holdings
SymbolNameShare %
CAMind Medicine Mindmed ...15.9%
CMPSCompass Pathways Plc A...6.86%
GHRSGh Research Plc5.89%
NRXPNRX Pharmaceuticals In...5.63%
ITCIIntra-Cellular Therapi...5.21%
MUAtai Life Sciences BV4.93%
ALKSAlkermes Plc4.87%
VTGNVistagen Therapeutics ...4.76%